Prevalence of spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia. 1994

L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
Department of Epidemiology and Genetics Rheumatic Diseases, Institute of Rheumatology RAMS, Moscow, Russia.

OBJECTIVE We sought to determine the prevalence and nature of spondyloarthropathies (SPA) and the prevalence of HLA-B27 in the native selected circumpolar population of Chukotka, Russia. METHODS We conducted a cross sectional study that included medical examinations and interviews of 355 of 498 (71.3%) native residents of 2 Eastern Chukotka settlements, Enmelen and Nunligran. RESULTS Among them were 268 Chukchas, 7 Eskimos, and 80 subjects of mixed race. There were 9 subjects (2.5%) with SPA, 3 of 7 Chukchas had ankylosing spondylitis (AS) (1.1%), 2 reactive arthritis (ReA), 2 with undifferentiated SPA. Among the mixed race persons one Chukcha-Eskimo had AS, one Eskimo-Russian had psoriatic arthritis (PsA). We found a high percentage of HLA-B27 antigen in the population, 34% in Chukcha natives and 25% in mixed race. CONCLUSIONS Our data complement other studies of circumpolar populations and reinforce the reported high prevalences of SPA and HLA-B27 among those populations.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003627 Data Interpretation, Statistical Application of statistical procedures to analyze specific observed or assumed facts from a particular study. Data Analysis, Statistical,Data Interpretations, Statistical,Interpretation, Statistical Data,Statistical Data Analysis,Statistical Data Interpretation,Analyses, Statistical Data,Analysis, Statistical Data,Data Analyses, Statistical,Interpretations, Statistical Data,Statistical Data Analyses,Statistical Data Interpretations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000091402 Prohibitins Ubiquitously expressed conserved proteins associated with multiple functions including APOPTOSIS; CELL PROLIFERATION, regulations of various immune and mitochondrial functions, and cellular stress responses. Prohibitin 1 and prohibitin 2 form a ring-shaped complex in the INNER MITOCHONDRIAL MEMBRANE. Prohibitin
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
January 1994, Terapevticheskii arkhiv,
L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
January 2009, Advances in experimental medicine and biology,
L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
July 1999, Current opinion in rheumatology,
L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
January 2009, Prion,
L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
January 2005, Acta medica portuguesa,
L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
April 1998, The Journal of rheumatology,
L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
October 1998, The American journal of the medical sciences,
L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
July 2000, Current opinion in rheumatology,
L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
July 2002, Current opinion in rheumatology,
L Alexeeva, and M Krylov, and V Vturin, and N Mylov, and S Erdesz, and L Benevolenskaya
January 2007, Immunology letters,
Copied contents to your clipboard!